Overexpression of miR-185-5p inhibits the polymerization of F-actin induced by S100A8/A9 and reverses epithelial–mesenchymal transition in breast cancer by modulating the receptor for advanced glycation end-products (RAGE) in vitro [15]. The gene discussed is AGER; the disease is breast carcinoma.